Back to top
more

Neogen (NEOG)

(Delayed Data from NSDQ)

$16.46 USD

16.46
1,260,843

-0.49 (-2.89%)

Updated Sep 25, 2024 04:00 PM ET

After-Market: $16.45 -0.01 (-0.06%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value C Growth C Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 28% (70 out of 252)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Balance Sheet

Research for NEOG

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

   

Fiscal Year End for Neogen Corporation falls in the month of May.

All items in Millions except Per Share data.

5/31/2024 5/31/2023 5/31/2022 5/31/2021 5/31/2020
Assets          
Cash & Equivalents 171 246 381 381 344
Receivables 173 153 100 92 85
Notes Receivable 0 0 0 0 0
Inventories 189 134 122 101 95
Other Current Assets 56 53 24 18 14
Total Current Assets 589 586 627 591 537
Net Property & Equipment 277 199 111 100 79
Investments & Advances 0 0 0 0 0
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 0 0 0 0 0
Intangibles 3,647 3,743 250 224 177
Deposits & Other Assets 20 15 2 2 2
Total Assets 4,549 4,554 993 920 797
Liabilities & Shareholders Equity 5/31/2024 5/31/2023 5/31/2022 5/31/2021 5/31/2020
Notes Payable 0 0 0 0 0
Accounts Payable 83 77 35 24 26
Current Portion Long-Term Debt 0 0 0 0 0
Current Portion Capital Leases 2 0 0 0 0
Accrued Expenses 31 62 41 28 21
Income Taxes Payable 10 7 2 2 1
Other Current Liabilities 27 0 0 0 0
Total Current Liabilities 154 145 78 54 48
Mortgages 0 0 0 0 0
Deferred Taxes/Income 327 353 17 22 18
Convertible Debt 0 0 0 0 0
Long-Term Debt 888 885 0 0 0
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 35 36 11 4 5
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 1,405 1,420 106 80 72
Shareholders Equity 5/31/2024 5/31/2023 5/31/2022 5/31/2021 5/31/2020
Preferred Stock 0 0 0 0 0
Common Stock (Par) 35 35 17 17 8
Capital Surplus 2,584 2,568 310 295 258
Retained Earnings 556 565 588 540 479
Other Equity -30 -33 -28 -11 -20
Treasury Stock 0 0 0 0 0
Total Shareholder's Equity 3,144 3,134 887 840 725
Total Liabilities & Shareholder's Equity 4,549 4,554 993 920 797
Total Common Equity 3,144 3,134 887 840 725
Shares Outstanding 216.60 216.20 107.80 107.00 105.40
Book Value Per Share 14.52 14.50 8.23 7.85 6.88

Fiscal Year End for Neogen Corporation falls in the month of May.

All items in Millions except Per Share data.

8/31/2024 5/31/2024 2/29/2024 11/30/2023 8/31/2023
Assets          
Cash & Equivalents -99,999 171 168 230 239
Receivables NA 173 174 151 138
Notes Receivable NA 0 0 0 0
Inventories NA 189 182 161 141
Other Current Assets NA 56 78 83 66
Total Current Assets NA 589 602 624 584
Net Property & Equipment NA 277 272 244 221
Investments & Advances NA 0 0 0 0
Other Non-Current Assets NA 0 0 0 0
Deferred Charges NA 0 0 0 0
Intangibles NA 3,647 3,676 3,703 3,726
Deposits & Other Assets NA 20 16 16 16
Total Assets NA 4,549 4,582 4,602 4,561
Liabilities & Shareholders Equity 8/31/2024 5/31/2024 2/29/2024 11/30/2023 8/31/2023
Notes Payable NA 0 0 0 0
Accounts Payable NA 83 90 112 90
Current Portion Long-Term Debt NA 0 0 0 0
Current Portion Capital Leases NA 2 3 3 3
Accrued Expenses NA 31 54 52 36
Income Taxes Payable NA 10 12 10 5
Other Current Liabilities NA 27 0 0 4
Total Current Liabilities NA 154 158 177 138
Mortgages NA 0 0 0 0
Deferred Taxes/Income NA 327 354 355 355
Convertible Debt NA 0 0 0 0
Long-Term Debt NA 888 888 887 886
Non-Current Capital Leases NA 0 0 0 0
Other Non-Current Liabilities NA 37 36 36
Minority Interest (Liabilities) NA 0 0 0 0
Total Liabilities NA 1,405 1,436 1,455 1,415
Shareholders Equity 8/31/2024 5/31/2024 2/29/2024 11/30/2023 8/31/2023
Preferred Stock NA 0 0 0 0
Common Stock (Par) NA 35 35 35 35
Capital Surplus NA 2,584 2,580 2,575 2,572
Retained Earnings NA 556 561 563 567
Other Equity NA -30 -29 -25 -27
Treasury Stock NA 0 0 0 0
Total Shareholder's Equity NA 3,144 3,146 3,148 3,146
Total Liabilities & Shareholder's Equity NA 4,549 4,582 4,602 4,561
Total Common Equity 0 3,144 3,146 3,148 3,146
Shares Outstanding 216.60 216.60 216.60 216.50 216.30
Book Value Per Share 0.00 14.52 14.53 14.54 14.55